Loading...
By the Editors
A series of articles in The BMJ describe how the vaginal mesh implant rose to prominence as a treatment for stress urinary incontinence and pelvic organ prolapse in the U.K. — only to become suspended two decades later over safety concerns. In fact, over 100,000 women worldwide are suing vaginal mesh manufacturers.
Editorialists say "the postmarketing assessment of vaginal mesh" is "a shameful episode in the history of implantable devices." The BMJ's three feature articles and two editorials, linked below, are worth a read.
Comment
LINK(S):
The BMJ feature #1 (Free)
The BMJ feature #2 (Free)
The BMJ feature #3 (Free)
The BMJ editorial #1 (Subscription required)
The BMJ editorial #2 (Subscription required)
Background: Physician's First Watch coverage of FDA reclassifying vaginal mesh as high risk (Free)